On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier

International Journal of Pharmaceutics

Volumn 495, Issue 1, 2015, Pages 572-578

  Li, Haoyu ^a   Li, Man ^a   Chen, Chao ^a   Fan, Aiping ^a   Kong, Deling ^a   Wang, Zheng ^a,b   Zhao, Yanjun ^a,b  

^a TIANJIN UNIVERSITY   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

Combinational delivery; Curcumin; Doxorubicin; Micelle; Stimuli responsive

Indexed keywords

CURCUMIN; DOXORUBICIN; NANOCARRIER; ANTINEOPLASTIC AGENT; DRUG CARRIER; LACTIC ACID; MACROGOL DERIVATIVE; MICELLE; MONOMETHOXYPOLYETHYLENE GLYCOL; NANOPARTICLE; POLYLACTIC ACID; POLYMER;

ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CRITICAL MICELLE CONCENTRATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; HEPG2 CELL LINE; HUMAN; HUMAN CELL; HYDRODYNAMICS; IC50; PH; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; CELL SURVIVAL; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECTS; DRUG POTENTIATION; MICELLE; PARTICLE SIZE; TIME FACTOR;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL SURVIVAL; CURCUMIN; DOXORUBICIN; DRUG CARRIERS; DRUG LIBERATION; DRUG SYNERGISM; HEP G2 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; INHIBITORY CONCENTRATION 50; LACTIC ACID; MICELLES; MICROSCOPY, CONFOCAL; NANOPARTICLES; PARTICLE SIZE; POLYETHYLENE GLYCOLS; POLYMERS; TIME FACTORS;

EID: 84942428710     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2015.09.022     Document Type: Article

References (25)

1. A.H. Abouzeid, N.R. Patel, I.M. Rachman, S. Senn, and V.P. Torchilin Anti-cancer activity of anti-GLUT1 antibody-targeted polymeric micelles co-loaded with curcumin and doxorubicin J. Drug Target. 21 2013 994 1000
2. Y. Cao, M. Gao, C. Chen, A. Fan, J. Zhang, D. Kong, Z. Wang, D. Peer, and Y. Zhao Triggered-release polymeric conjugate micelles for on-demand intracellular drug delivery Nanotechnology 26 2015 115101
3. T.C. Chou Drug combination studies and their synergy quantification using the Chou-Talalay method Cancer Res. 70 2010 440 446
4. J. Duan, H.M. Mansour, Y. Zhang, X. Deng, Y. Chen, J. Wang, Y. Pan, and J. Zhao Reversion of multidrug resistance by co-encapsulation of doxorubicin and curcumin in chitosan/poly(butyl cyanoacrylate) nanoparticles Int. J. Pharm. 426 2012 193 201
5. O.C. Farokhzad, and R. Langer Impact of nanotechnology on drug delivery ACS Nano 3 2009 16 20
6. A.P. French, S. Mills, R. Swarup, M.J. Bennett, and T.P. Pridmore Colocalization of fluorescent markers in confocal microscope images of plant cells Nat. Protoc. 3 2008 619 628
7. M. Gao, C. Chen, A. Fan, J. Zhang, D. Kong, Z. Wang, and Y. Zhao Covalent and non-covalent curcumin loading in acid-responsive polymeric micellar nanocarriers Nanotechnology 26 2015 275101
8. Y. Gu, Y. Zhong, F. Meng, R. Cheng, C. Deng, and Z. Zhong Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy Biomacromolecules 14 2013 2280 2772
9. X. Li, J. Qin, and J. Ma Silk fibroin/poly (vinyl alcohol) blend scaffolds for controlled delivery of curcumin Regen. Biomater. 2 2015 97 106
10. E. Markovsky, H. Baabur-Cohen, and R. Satchi-Fainaro Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs J. Control. Release 187 2014 145 157
11. F. Meng, R. Cheng, C. Deng, and Z. Zhong Intracellular drug release nanosystems Mater. Today 15 2012 436 442
12. R. Misra, and S.K. Sahoo Coformulation of doxorubicin and curcumin in poly(D,L-lactide-co-glycolide) nanoparticles suppresses the development of multidrug resistance in K562 cells Mol. Pharm. 8 2011 852 866
13. S. Mura, J. Nicolas, and P. Couvreur Stimuli-responsive nanocarriers for drug delivery Nat. Mater. 12 2013 991 1003
14. P. Parhi, C. Mohanty, and S.K. Sahoo Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy Drug Discov. Today 17 2012 1044 1052
15. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760
16. Y. Sadzuka, M. Nagamine, T. Toyooka, Y. Ibuki, and T. Sonobe Beneficial effects of curcumin on antitumor activity and adverse reactions of doxorubicin Int. J. Pharm. 432 2012 42 49
17. G.K. Such, Y. Yan, A.P. Johnston, S.T. Gunawan, and F. Caruso Interfacing materials science and biology for drug carrier design Adv. Mater. 27 2015 2278 2297
18. V.P. Torchilin Micellar nanocarriers: pharmaceutical perspectives Pharm. Res. 24 2007 1 16
19. B. Wang, Y. Shen, Q. Zhang, Y. Li, M. Luo, Z. Liu, Y. Li, Z. Qian, X. Gao, and H. Shi Codelivery of curcumin and doxorubicin by MPEG-PCL results in improved efficacy of systemically administered chemotherapy in mice with lung cancer Int. J. Nanomed. 8 2013 3521 3531
20. Z. Wang, C. Chen, R. Liu, A. Fan, D. Kong, and Y. Zhao Two birds with one stone: dendrimer surface engineering enables tunable periphery hydrophobicity and rapid endosomal escape Chem. Commun. 50 14 2014 025 14028
21. Z. Wang, C. Chen, Q. Zhang, M. Gao, J. Zhang, D. Kong, and Y. Zhao Tuning the architecture of polymeric conjugate to mediate intracellular delivery of pleiotropic curcumin Eur. J. Pharm. Biopharm. 90 2015 53 62
22. M.M. Yallapu, M. Jaggi, and S.C. Chauhan Curcumin nanoformulations: a future nanomedicine for cancer Drug Discov. Today 17 2012 71 80
23. R. Yang, S. Zhang, D. Kong, X. Gao, Y. Zhao, and Z. Wang Biodegradable polymer-curcumin conjugate micelles enhance the loading and delivery of low-potency curcumin Pharm. Res. 29 2012 3512 3525
24. X. Zhao, Q. Chen, Y. Li, H. Tang, W. Liu, and X. Yang Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice Eur. J. Pharm. Biopharm. 93 2015 27 36
25. Y. Zhao, M. Moddaresi, S.A. Jones, and M.B. Brown A dynamic topical hydrofluoroalkane foam to induce nanoparticle modification and drug release in situ Eur. J. Pharm. Biopharm. 72 2009 521 528